Gurnek Singh
About Gurnek Singh
Gurnek Singh is a Business Development Lead at InstaDeep Ltd, specializing in BioAI. He has extensive experience in business development and product management across various organizations, including Quazel and Kognito, and holds degrees from prestigious institutions such as Stanford University and the University of Chicago.
Current Role at InstaDeep
Gurnek Singh serves as the Business Development Lead for BioAI at InstaDeep Ltd. He has been in this position since 2022, operating out of San Francisco, California. In this role, he focuses on developing business strategies and partnerships that leverage artificial intelligence in the biotechnology sector.
Previous Experience at Quazel
Before joining InstaDeep, Gurnek Singh co-founded Quazel, where he worked for one year from 2022 to 2023 in San Francisco, California. His role involved driving business initiatives and fostering innovation within the company.
Professional Background in Business Development
Gurnek Singh has extensive experience in business development. He held the position of Senior Director of Business Development at Kognito from 2018 to 2020 in Baltimore, MD. He also served as Head of Product for Healthcare at Kognito from 2020 to 2021, where he contributed to product strategy and market positioning.
Educational Qualifications
Gurnek Singh has a strong educational background in computer science and business. He studied at the University of Chicago, earning a degree in Computer Science. He also holds a Bachelor of Science in Biological Sciences from Stanford University and an MBA from the University of California, Berkeley, Haas School of Business. Additionally, he completed certificates in C++ Language Proficiency and Enterprise Database Proficiency at the College of DuPage.
Achievements in Biotechnology and AI
Gurnek Singh has partnered with industry leaders to develop deep learning models in genomics and proteomics. His work focuses on discovering druggable targets and accelerating therapeutic development. He has also engineered optimized bioreactor catalysts and developed a Go-To-Market strategy for various sectors, including agriculture and industrial chemicals.